SEI Investments’s Kura Oncology KURA Stock Holding History

SEI Investments’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.78M	Sell	162,110 -157,156	-49%	-$1.48M	﹤0.01%	2010
2026 Q1	$2.6M	Buy	319,266 +135,818	+74%	+$1.17M	﹤0.01%	1877
2025 Q4	$1.91M	Buy	+183,448	New	+$1.92M	﹤0.01%	1876
2025 Q1	–	Sell	-20,815	Closed	-$181K	–	2800
2024 Q4	$181K	Buy	20,815 +6,055	+41%	+$87.1K	﹤0.01%	2492
2024 Q3	$288K	Sell	14,760 -355	-2%	-$7.19K	﹤0.01%	2366
2024 Q2	$311K	Sell	15,115 -2,653	-15%	-$54.5K	﹤0.01%	2322
2024 Q1	$379K	Buy	+17,768	New	+$345K	﹤0.01%	2217
2020 Q4	–	Sell	-23,353	Closed	-$716K	–	2497
2020 Q3	$716K	Buy	+23,353	New	+$516K	﹤0.01%	1753

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

SEI Investments's KURA Position: Q2 2026 in Review

SEI Investments reduced its Kura Oncology (KURA) stake by 49% in Q2 2026, selling an estimated $1.48M and leaving 162,110 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2010.

SEI Investments first reported a position in KURA in Q3 2020 and has held it in 8 quarters since. The position peaked at $2.6M in Q1 2026. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

SEI Investments held 162,110 shares of Kura Oncology worth $1.78M as of Q2 2026.
SEI Investments sold 157,156 Kura Oncology shares in Q2 2026, an estimated $1.48M.
Kura Oncology made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2010 holding.
SEI Investments first reported a position in Kura Oncology in Q3 2020 and has held it in 8 quarters since.
SEI Investments's Kura Oncology position peaked at $2.6M in Q1 2026.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.